U.S. stock markets experienced a downturn on Thursday, with the Nasdaq Composite shedding over 170 points and ending the day at 19,338.29. The Dow decreased by almost 0.2% to 43,153.13, while the S&P 500 fell 0.2% to 5,937.34.
These are the top stocks that gained the attention of retail traders and investors throughout the day:
Apple Inc. AAPL
Apple’s shares fell 4.04%, closing at $228.26, with an intraday high of $238.01 and a low of $228.03. The stock is trading between its 52-week high of $260.09 and low of $164.08. The decline follows a report indicating a significant drop in iPhone sales in China, with Canalys data showing a 17% annual decrease in shipments, marking Apple’s largest sales drop in the region.
Rivian Automotive Inc. RIVN
Rivian’s stock rose 3.59% to close at $14.44, reaching an intraday high of $14.66 and a low of $13.95. The stock’s 52-week range is $18.86 to $8.26. The increase came after Rivian finalized a loan agreement with the U.S. Department of Energy for up to $6.6 billion, aimed at supporting the construction of a new manufacturing facility in Georgia.
UnitedHealth Group, Inc. UNH
UnitedHealth shares dropped 6.04%, closing at $510.59, with a high of $539.84 and a low of $510. The stock’s 52-week high is $630.73, and the low is $436.38. The decline follows mixed financial results, with earnings exceeding estimates but revenue falling short by nearly $1 billion, amid challenges like Medicare funding reductions.
Biomerica, Inc. BMRA
Biomerica’s stock surged 101.71% to $0.71, with an intraday high of $1.27 and a low of $0.56. The stock’s 52-week range is $1.35 to $0.24. The dramatic rise follows the approval of its Fortel Prostate Specific Antigen Screening Test by the United Arab Emirates Ministry of Health and Prevention.
Tesla Inc. TSLA
Tesla’s shares decreased by 3.36%, closing at $413.82, with a high of $424 and a low of $409.13. The stock trades between a 52-week high of $488.54 and a low of $138.8. The decline comes as an analyst from Goldman Sachs highlighted Tesla’s monetization opportunities with robotaxis and full self-driving technology, maintaining a Neutral rating.
Prepare for the day’s trading with top premarket movers and news by Benzinga.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.